The Value of MRI in Distinguishing Subtypes of Lipomatous Extremity Tumors Needs Reassessment in the Era of MDM2 and CDK4 Testing.
Sean P RyanJulia VisgaussDavid KerrJoshua HelmkampNicholas SaidEmily VinsonPatrick O'DonnellXuechan LiSin-Ho JungDiana CardonaWilliam EwardBrian BrigmanPublished in: Sarcoma (2018)
The accuracy of both our readers and the formula suggests that MRI remains unreliable for distinguishing between lipoma and WDLs.